Development of antimalarial drugs and their application in China: a historical review
Tóm tắt
This historical review covers antimalarials developed in China, which include artemisinin, artemether, artesunate, and dihydroartemisinin, as well as other synthetic drugs such as piperaquine, pyronaridine, benflumetol (lumefantrine), and naphthoquine. The curative effects of these antimalarials in the treatment of falciparum malaria, including chloroquine-resistant strain, are especially discussed. Following the World Health Organization (WHO) recommended artemisinin-based combination therapy (ACT), different combinations of artemisinin, or its derivative, along with another antimalarial drug were orally used to treat Plasmodium falciparum infections. The recrudescence rates were low, gametocyte carriers lessened, and the curative rate increased remarkably. The combination therapy effectively deferred the emergence of drug resistance in the parasite. The regulation “The guidelines and regimens for the use of antimalarial drugs in China” was issued to guide rational application and standardize malaria treatment in the country. As the recommended first-line drug to treat falciparum malaria in the world, ACT was adopted in the regulation. In response to the global initiative of malaria eradication proposed by the UN Millennium Development Goals (MDGs), the Chinese government has set a target to eliminate malaria by 2020.
Tài liệu tham khảo
Zhou ZJ: The studies and control on malaria in China. 1991, Beijing: People’s Medical Publishing House, (in Chinese)
Moore DV, Lanier JE: Observations on studies on two Plasmodium falciparum infections with an abnormal response to chloroquine. Am J Trop Med Hyg. 1961, 10: 5-9.
Department of Disease Control, Ministry of Health of the People’s Republic of China: The manual of Malaria Control. 2007, Beijing: People’s Medical Publishing House, 274-277. (in Chinese), 3
WHO: Guideline for the treatment of malaria. 2010, Geneva, 2
Zhang YZ: History of qinghao used as a drug and investigation of species. Chin Pharm Bull. 1981, 16: 197-200. (in Chinese)
Coordinating Research Group for the Structure of Artemisinin: A new type of sesquiterpene lactone---artemisinin. Chin Sci Bull. 1977, 22: 142-(in Chinese)
Xu XX, Zhu J, Huang DZ, Zhou WS: Studies on structure and syntheses of arteannuin and related compound X. The stereocontrolled syntheses of arteannuin and deoxyarteannuin from arteannuic acid. Acta Chim Sin. 1983, 41: 574-576. (in Chinese)
China Cooperative Research Group on Qinghaosu and Its Derivative as Antimalarials: Antimalarial efficacy and mode of action of qinghaosu and its derivatives in experimental models. J Trad Chin Med. 1982, 2: 17-24.
Qinghaosu Antimalaria Coordinating Research Group: Antimalaria studies on qinghaosu. Chin Med J. 1979, 92: 811-816.
China Cooperative Research Group on Qinghaosu and Its derivatives as Antimalarials: Metabolism and pharmacokinetics of qinghaosu and its derivatives. J Trad Chin Med. 1982, 2: 25-30.
Li Y, Yu PL, Chen YX, Li LQ, Gai YZ, Wang DS, Zheng YP: Synthesis of some derivatives of artemisinine. Chin Sci Bull. 1979, 24: 667-669. (in Chinese)
Qiao GF, Yang BF, Li WH, Li BY: Effects of artemisinin on action potentials from C-type nodose ganglion neurons. Acta Pharmacol Sin. 2003, 24: 937-942. (in Chinese)
China Cooperative Research Group on Qinghaosu and its Derivatives as Arntimalarials: Studies on the toxicity of qinghaosu and its derivatives. J Trad Chin Med. 1982, 2: 31-38.
Yang BF, Luo DL, Bao LH, Zhang YC, Wang HZ: Artemisinin blocks activity and slowly activating K+ current in guinea pig ventricular. Acta Pharmacol Sin. 1988, 19: 269-272. (in Chinese)
Li ZL, Yang LX, Liu JF, Bi Y, Li GQ, Dai BQ, Ren N: Study on teratogensis of sodium artesunate. Bull Chin Mater Med. 1988, 13: 234-236. (in Chinese)
Wang YL, Ding JX: Studies on the stability of artemether tablet. Chin Trad Herb Drug. 1989, 20: 297-299. (in Chinese)
Liang J, Jiang YS, Hua XY: Preparation of artemether injection and its antimalarial efficacy. Chin Trad Herb Drug. 1989, 20: 348-(in Chinese)
Zeng YL, Zhang YD, Xu GY, Wang CG, Jiang JR: The pharmacokinetics and bioavailability of o-methyldihydroartemisinin in the rabbit. Acta Pharm Sin. 1984, 19: 81-84. (in Chinese)
China Cooperative Research Group on Qinghaosu and its Derivatives as Antimalarials: Clinical studies on the treatment of malaria with qinghaosu and its derivatives. J Trad Chin Med. 1982, 2: 45-50.
Li GQ, Guo XB, Wang WL, So YY, Jian HX, Li ZY, Wang XC, Han MF: Clinical research on treatment of falciparum malaria by artemether injection. Natl Med J Chin. 1982, 62: 293-294. (in Chinese)
Wang ZH, Jian Z, Huang MZ, Huang FY, Zhang ZW: Observation on 63 cases with malignant malaria treated with single dose of artemether combined with anti-malarial II. Chin J Infect Dis. 1985, 3: 247-248. (in Chinese)
Che LG, Zhang YL, Li XL, Shu WY, Zhang X, Li CF, Liu H, Li ZH: Clinical Study on artemether co. against drug-resistant falciparum malaria. Chin J Parasit Dis Control. 1995, 8: 244-246. (in Chinese)
Liu X: Study on artemisinin derivatives. Chin Pharm Bull. 1980, 15: 183-(in Chinese)
Zhao KC, Chen ZX, Lin BL, Guo XB, Li GQ, Song ZY: Studies on the clinical pharmacokinetics in phase I of artesunate and artemether. Chin J Clin Pharmacol. 1988, 4: 76-81. (in Chinese)
Guo WZ, Guo XB, Zheng QJ, Tan BO, Chen RJ, Ou FZ, Fu LC: A randomized comparative study of naphthoquine, mefluquine and artesunate in the treatment of falciparum malaria. Natl Med J Chin. 2003, 83: 1406-1408. (in Chinese)
Fu LC, Wang XH, Wang WL, Guo XB, Jian HX, Li GQ: Clinical analysis of artesunate on 106 patients with cerebral malaria. Natl Med J Chin. 1995, 75: 296-297. (in Chinese)
Li CS, Du YL, Zhang CL, Zhao XJ: Pharmacodynamics of dihydroartemisinine against Plasmodium berghei in mice. Acta Pharm Sin. 1989, 24: 487-489. (in Chinese)
Li XL, Yang CJ: A comparative clinical trial of dihydroartemisinin tablet for 5 d and 7 d course of treatment to falciparum and vivax malaria. J Pract Parasit Dis. 1975, 3: 66-68. (in Chinese)
Zheng LZ, Chen H, Cai XZ: Clinical trial of dihydroartemisinin in treatment of falciparum malaria. Hainan Med J. 1995, 6: 139-140. (in Chinese)
Zhou ZJ, Zhu FY, Wang JX, Fang TZ, Zhu ZL: Elective cultivation of chloroquine-resistant strain of Plasmodium berghei in mice. 1972, Shanghai: Annual Report of Institute of Parasitic Diseases, Chinese Academy of Preventive Medicine, 183-187. (in Chinese)
Chen Q, Deng JL, Wu DL, Zhang LM, Zheng XL: Studies on absorption, distribution and excretion of 14C-piperaquine phosphate and 14C-piperaquine in vivo. Pharm Industry. 1979, 8: 19-23. (in Chinese)
Chen L, Qian YL, Li ZL, Zhang KH, Dai BQ, Liu ZF, Wang JL: Effects of piperaquine on fine structure of erythrocytic stages of Plasmodium berhei ANKA strain. Acta Pharmacol Sin. 1986, 7: 351-353. (in Chinese)
Chen L, Qu FY, Zhou YC: Field observation on a new antimalarial drug— piperaquine. Med J PLA. 1979, 4: 104-108. (in Chinese)
Lan CX, Lin X, Huang ZS, Chen YS, Guo RN: In vivo sensitivity of Plasmodium falciparum to piperaquine phosphate assayed in Linshi and Baisha counties, Hainan Province. Chin J Parasitol Parasit Dis. 1989, 7: 163-165. (in Chinese)
Guo XB, Fu YX, Chen PQ, Lin JZ, Xie DE, Su HM, Li GQ: Clinlcal observations on 100 cases of malignant malaria with artesunate tablets. Natl Med J Chin. 1989, 69: 515-516. (in Chinese)
Yang HL, Liu DQ, Huang KG, Yang YM, Yang PF, Liao MZ, Zhang CY: Assay of sensitivity of Plasmodium falciparum to chloroquine, amodiaquine, piperaquine, mefloquine and quinine in Yunnan Province. Chin J Parasitol Parasit Dis. 1999, 17: 43-45. (in Chinese)
Guo XB, Fu LC, Fu YX, Qian BS, Li GQ: Randomised comparison on the treatment of falciparum malaria with dihydroartemisinin and piperaquine. Natl Med J Chin. 1993, 73: 602-604. (in Chinese)
New Drug Group of the Former Research Department of Malaria: Experimental studies on chemotherapeutic effects and toxicities of a new antimalarial drug 7351. Acta Pharm Sin. 1980, 15: 630-632. (in Chinese)
Fu S, Björkman A, Wåhlin B, Ofori-Adjei D, Ericsson ö, Sjöqvist F: In vitro activity of chloroquine, the two enantiomers of chloroquine, desethyl-chloroquine and pyronaridine against Plasmodium falciparum. Br J Clin Pharmacol. 1986, 22: 93-96.
Wu LJ: Effect of pyronaridine on ultrastructure of erythrocytic forms of Plasmodium berghei in mice. Acta Pharmacol Sin. 1985, 6: 280-283. (in Chinese)
Wu LJ: Ultrastructural study on the effect of pyronaridine on erythrocytic stages of chloroquine-resistant strain of Plasmodium berghei. J Parasitol Parasit Dis. 1986, 4: 263-266. (in Chinese)
Wu LJ, Rabbege JR, Nagasawa H, Jacobo G, Aikawa M: Morphological effects of pyronaridine on malarial parasites. Am J Trop Med Hyg. 1988, 38: 30-36.
Kawai S, Kano S, Chen C, Suzuki M: The effects of pyronaridine on the morphology of Plasmodium falciparum in Aotus trivirgatu s. Am J Trop Med Hyg. 1996, 55: 223-229.
Feng Z, Wu ZF, Wang CY, Jiang NX: Pharmacokinetics of pyronaridine in malaria patients. Acta Pharmacol Sin. 1987, 8: 543-546. (in Chinese)
Jayaraman SD, Ismail S, Nair NK, Navaratnam V: Determination of pyronaridine in blood plasma by high-performance liquid chromatography for application in clinical pharmacological studies. J Chromatog B. 1997, 690: 253-257.
Ni YC, Zhan CQ, Ha SH, Shao BR: The embryotoxicity of a new antimalarial pyronaridine in rats. Acta Pharm Sin. 1982, 17: 401-406. (in Chinese)
Pyronaridine Research Cooperation Group: Efficacy of pyronaridine on 510 acute malaria cases. Chin J Intern Med. 1985, 24: 646-647. (in Chinese)
Ringwald P, Bickii J, Basco LK: Randomized trial of pyronaridine versus chloroquine for acute uncomplicated falciparum malaria in Africa. Lancet. 1996, 347: 24-28. 10.1016/S0140-6736(96)91558-5.
Ringwald P, Bickii J, Basco LK: Efficacy of oral pyronaridine for the treatment of acute uncomplicated falciparum malaria in Africa children. Clin Infect Dis. 1998, 26: 946-953. 10.1086/513942.
Ringwald P, Bickii J, Same-Ekobo A, Basco LK: Pyronaridine for treatment of Plasmodium ovale and Plasmodium malariae infections. Antimicrob Agents Chemother. 1997, 41: 2317-2319.
Deng RX, Zhong JX, Zhao DC, Zhang HB, Sheng XY, Ding DB, Yang JD: Synthesis and antimalarial activity of fluorenementhanols. Acta Pharm Sin. 1997, 32: 874-878. (in Chinese)
Deng RX: Recent progress in research on antimalaarials drugs in China. Chin J Pharm. 1989, 20: 372-376. (in Chinese)
WHO: Practical Chemotherapy of Malaria Technical Report: Report of a WHO Scientific Group. 1990, Geneva: WHO, 124-126.
Institute of Microbiology and Epidemiology: Treatment of chloroquine-resistant falciparum malaria with an antimalarial–-No 76028. Med J PLA. 1981, 6: 260-262. (in Chinese)
Sun ZW, Shan CQ, Li GF, Wang JY, Ding DB, Liu GY, Jiao XQ: Treatment effects of co-artemether and benflumetol capsule in naturally occurring falciparum malaria patients. J Pract Parasit Dis. 1999, 7: 49-51. (in Chinese)
Li FL, Wang LH, Ding DB, Yang JD, Gao XS: Studies on antimalarials: Synthesis of 4-arylamino-tert-butylaminomethyl phonols. Acta Pharm Sin. 1982, 17: 77-79. (in Chinese)
Pen XJ, Wang GZ, Ying QL, Chen YH, Xu MS: Effect of treatment of 101 falciparum malaria cases with naphthoquine phosphate. Chin J Parasitol Parasit Dis. 1999, 17: 20-(in Chinese)
Liu DQ, Liu RJ, Zhang CY, Cai XZ, Tang X, Yang HL, Yang PF, Dong Y: Present status of the sensitivity of Plasmodium falciparum to antimalarials in China. Chin J Parasitol Parasit Dis. 1996, 14: 37-41. (in Chinese)
Yang HL, Yang H: A case report of artemether-resistant falciparum malaria. Chin J Parasitol Parasit Dis. 1991, 9: 125-(in Chinese)
Yang CJ: A cases report of artemether-resistant falciparum malaria. J Pract Parasit Dis. 2000, 8: 101-(in Chinese)
Gogtay NJ, Kadam VS, Karnad DR, Kanbur A, Kamtekar KD, Kshirsagar NA: Probable resistance to parenteral artemether in Plasmodium falciparum: Case reports from Mumbai (Bombay), India. Ann Trop Med Parasitol. 2000, 94: 519-520.
Treeprasertsuk S, Viriyavejakul P, Silachamroon U, Vannphan S, Wilairatana P, Looareesuwan S: Is there any artemisinin resistance in falciparum malaria?. Southeast Asian J Trop Med Public Health. 2000, 31: 825-828.
Su LG, Wang Y, Jia J: Two cases of artemether-resistant falciparum malaria. Chin J Parasit Dis Control. 2001, 14: 66-(in Chinese)
Yang HL, Zhang ZY: A case report of repeated recurring malaria. Chin J Parasitol Parasit Dis. 2002, 20: 200-(in Chinese)
Sun XD, Zhang ZX, Liu DQ, Huang GZ, Den Y, Zhang CL, Wang SL, Li HB, Huang M, Jiang YC, Zhao LF, Xiao YJ: Clinical study on the efficacy of dihydroartemisinin and piperaquine in treatment of multi-drug resistant Plasmodium falciparum. Chin Trop Med. 2006, 6: 211-212. (in Chinese)
Song JP, Fu LC, Tan B, Li GQ: Randomized controlled trial of dihydroartenisinin piperaquine and phosphate tablet in treating of uncomplicated falciparum malaria. Chin J New Drugs Clin Rem. 2004, 23: 783-785. (in Chinese)
Peng CM, Ousseini H: Efficacy of dihydroartemisinin-piperaquine tablets made in China in treatment of falciparum malaria in Africa. Chin Trop Med. 2009, 9: 1462-1463. (in Chinese)
Song JP, Duong S, Thou T, Ses S, Sim Y, Tan B, Li GQ: Observation of clinic on compound of dihydroartemisinin and piperaquine in treatment of uncomplicated falciparum. Natl Med J Chin. 2003, 83: 1099-1100. (in Chinese)
Wang SQ, Eva C, Lin SG, Meng F, Hu XM, Wang GZ, Lin J, Zeng LH: Efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in Hainan, China. Clin J Parasitol Parasit Dis. 2008, 26: 50-52. (in Chinese)
Liu H, Yang HL, Zhang J, Li CF, Nie RU, Wang HY: Efficacy of compound dihydroartemisinin/piperaquine in treatment of uncomplicated falciparum malaria in Myanmar. Chin J Parasotol Parasit Dis. 2011, 29: 296-298. (in Chinese)
Sun XD, Zhang ZX, Wang J, Deng Y, Yang YC, Lasi J-H, Sun XY, Wang H: Therapeutic efficacy and safely of compound dihydroartemisinin/piperaquine for uncomplicated Plasmodium falciparum in Laiza city of Myanmer bordering on China. Chin J Parasitol Parasit Dis. 2011, 29: 372-375. (in Chinese)
Shen CQ, Liu GY, Jiao XQ: Clinical efficacy of co-artemether in the patient with falciparum malaria. Acta Parasitol Med Entomol Sin. 2005, 12: 14-16. (in Chinese)
Wang JY, Shan CQ, Fu DD, Sun ZW, Ding DB: Efficacy of naphthoquine, artemisinin and a combination of two drugs in the treatment of falciparum malaria. Chin J Parasitol Parasit Dis. 2003, 21: 131-133. (in Chinese)
Liu DQ, Lin SG, Feng XP, Chen WJ, Chen PL, Wu HM, Chen C, Liu J: Study on treatment of multi-drug resistant falciparum malaria by using a combination of dihydroartemisinin and pyronaridine. Chin J Parasitol Parasit Dis. 2002, 20: 193-196. (in Chinese)
Shang LY, Han QX: Observation on efficacy of pyronaridine phosphate and it combined with dihydroartemisinin for treatment of malaria in Eritrea, Africa. Chin J Parasit Dis Control. 2001, 14: 171-173. (in Chinese)
Cai XZ, Chen C, Zheng XY, Wang XF: Perliminary study of dihydroartemisinin combined with pyronaridine for treatment of falciparum malaria. J Pract Parasit Dis. 1999, 7: 104-105. (in Chinese)
Cai XZ, Che LG, Chen C, Zheng XY, Wang XF: Clinical efficacy of artemether or artesunate combined with pyronaridie in treatment of falciparum malaria. J Pract Parasit Dis. 1999, 7: 156-158. (in Chinese)
Kanyok T: The pyronaridine-artesunate project for treatment of uncomplicated malaria. TDR News. 2001, 65: 10-
Breckenridge A: Risk and benefits of prophylactic antimalarial drugs. BMJ. 1989, 299: 1057-1058. 10.1136/bmj.299.6707.1057.
Xia ZG, Feng J, Zhou SS: Malaria situation in the People’s Republic of China in 2012. Chin J Parasitol Parasit Dis. 2013, 31: 413-418. (in Chinese)
Lei ZL, Wang LY: Control situation and primary task of key parasitic diseases in China. Chin J Parasitol Parasit Dis. 2012, 30: 1-5. (in Chinese)